Literature DB >> 2320388

The capability of neonatal leukocytes to produce IL-6 on stimulation assessed by whole blood culture.

A Yachie1, N Takano, T Yokoi, K Kato, Y Kasahara, T Miyawaki, N Taniguchi.   

Abstract

IL-6 is a cytokine with a wide variety of influences on the cells involved in immune and inflammatory responses. Defective production of IL-6 may be partly responsible for the impaired immune defense and inflammatory response often observed in the neonatal period. In our study, we used whole blood culture to examine the capacity of neonatal leukocytes to produce IL-6 in response to various stimuli. IL-6 activity was evaluated by growth promoting assay using an IL-6-dependent murine hybridoma clone. IL-6 activity was undetectable in fresh or unstimulated blood obtained from both newborns and adults. In contrast, incubation of whole blood with lipopolysaccharide or concanavalin A resulted in marked IL-6 activity. After stimulation, IL-6 activity was induced as early as 2 h after culture and increased with time, reaching a plateau at around 12 h. Comparative examinations suggested that the IL-6 activity induced in neonatal blood on stimulation was similar to that seen in stimulated adult blood. Neutralization experiments with anti-IL-6 anti-serum confirmed the presence of IL-6 proteins in the stimulated blood, and induction of cellular IL-6 mRNA was demonstrated in the stimulated blood as well. In addition, immunocytochemical observations suggested that the major IL-6 producing cells in the stimulated blood may be monocytes. The results suggest that the production of IL-6 in response to specified stimuli is normal at birth.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2320388     DOI: 10.1203/00006450-199003000-00005

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  7 in total

Review 1.  Microorganisms in the Placenta: Links to Early-Life Inflammation and Neurodevelopment in Children.

Authors:  Martha Scott Tomlinson; Kun Lu; Jill R Stewart; Carmen J Marsit; T Michael O'Shea; Rebecca C Fry
Journal:  Clin Microbiol Rev       Date:  2019-05-01       Impact factor: 26.132

2.  Lipopolysaccharide binding protein in preterm infants.

Authors:  D Behrendt; J Dembinski; A Heep; P Bartmann
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-11       Impact factor: 5.747

3.  Defective production of interleukin-6 in very small premature infants in response to bacterial pathogens.

Authors:  A Yachie; N Takano; K Ohta; T Uehara; S Fujita; T Miyawaki; N Taniguchi
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

Review 4.  Fetal inflammatory response and brain injury in the preterm newborn.

Authors:  Shadi Malaeb; Olaf Dammann
Journal:  J Child Neurol       Date:  2009-07-15       Impact factor: 1.987

5.  Interleukin-3, interleukin-6, granulocyte-macrophage colony-stimulating factor and erythropoietin cord blood levels of preterm and term neonates.

Authors:  B Meister; M Herold; A Mayr; M Widschwendter; H Maurer; K Heim; W Sperl
Journal:  Eur J Pediatr       Date:  1993-07       Impact factor: 3.183

6.  Beneficial effects of interleukin-6 in neonatal mouse models of group B streptococcal disease.

Authors:  G Mancuso; F Tomasello; M Migliardo; D Delfino; J Cochran; J A Cook; G Teti
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

7.  Circulating cytokine concentrations and cytokine production by monocytes from newborn babies and adults.

Authors:  V Pillay; N Savage; H Laburn
Journal:  Pflugers Arch       Date:  1994-10       Impact factor: 3.657

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.